摘要:
Methods are described for predicting ancestral sequences for viruses or portions thereof. Also described are predicted ancestral sequences for adeno-associated virus (AAV) capsid polypeptides. The disclosure also provides methods of gene transfer and methods of vaccinating subjects by administering a target antigen operably linked to the AAV capsid polypeptides.
摘要:
In at least one embodiment, a medical device can comprise an elongate outer sheath that extends along a sheath longitudinal axis and defines a central lumen extending therethrough, the elongate outer sheath can comprise a proximal sheath portion and a distal sheath portion. A first guidewire can comprise a first guidewire end and a second guidewire end, the first guidewire can extend from the first and second guidewire ends through the central lumen and can form a distal looped portion. An occlusion device can be disposed at a distal end of an elongate flexible shaft. The elongate flexible shaft can extend from the proximal sheath portion through the central lumen. The occlusion device can include a guide lumen through which the first guide wire passes.
摘要:
A fermentation process for fermenting a starch hydrolysate containing 60-98 weight percent of glucose based on total carbohydrate and 0.3-5% weight percent of isomaltose based on total carbohydrate to a non-ethanol fermentation product is carried out. The method comprises: a) forming a fermentation broth containing the starch hydrolysate and a genetically modified microorganism containing i) an exogenous gene encoding transporter capable of transporting isomaltose ii) an exogenous gene encoding an enzyme capable of converting isomaltose to glucose; and b) fermenting the starch hydrolysate in the fermentation broth to produce a non-ethanol fermentation product. This fermentation process may be carried out as a single step fermentation or a batch process. The genetically modified microorganism may contain an exogenous gene encoding an enzyme that catalyzes the formation of a product other than ethanol.
摘要:
The invention provides a method for detecting one or more mutations or genetic variations in a blood, serum, or plasma sample of a subject having cancer or suspected of having cancer, the method comprising: identifying a plurality of mutations or genetic variations in a tumor sample of the subject by whole exome sequencing; collecting a blood, serum, or plasma sample from the subject, and isolating cell-free DNA from the blood, serum, plasma, or tumor sample; amplifying a plurality of loci corresponding to the mutations or genetic variations from the cell-free DNA to obtain amplicons; sequencing the amplicons to obtain sequence reads; and detecting one or more of the mutations or genetic variations present in the cell-free DNA from the sequence reads; optionally wherein the cell-free DNA comprises circulating tumor DNA.